| Title： | Pharmaceutical management of biologics for the treatment of osteoporosis: a rapid guideline |
| Edition： | Original |
| Classification： | Rapid advice guideline |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | GRADE |
| Development unit： | Committee of Evidence-based Pharmacy, Chinese Pharmaceutical Society |
| Registration time: | 2022-07-08 |
| Registration number： | IPGRP-2022CN386 |
| Purpose of the guideline: |
Latest registration
